Table 1.
Demographic characteristics and general features of survey participants (n=200)
| Features | % (n) |
|---|---|
| Age | |
| Median (IQR)= 36 (7) (range: 26-84) | |
| Mean (±SD) = 38.87 (9.5) | |
| Gender | |
| Man | 51.5 (103) |
| Woman | 47.5 (95) |
| I prefer not to answer | 1 (2) |
| Academic degree | |
| MD | 71 (142) |
| MD/PhD or MD/MSc | 18.5 (37) |
| PhD | 7 (14) |
| PharmD/MPharm | 2 (4) |
| Other‡ | 1.5 (3) |
| Current oncology specialty | |
| Clinical Oncology disciplines | 91.5 (183) |
| Medical Oncology | 54 (108) |
| Radiation Oncology | 17 (34) |
| Clinical Oncology | 18.5 (37) |
| Haematology/Oncology | 2 (4) |
| Surgical Oncology | 2.5 (5) |
| Oncology Pharmacy | 4.5 (8) |
| Other specialties¥ | 1.5 (4) |
| Current position | |
| Specialist doctor/Attending physician | 59 (118) |
| Resident physician/Physician in training | 14.5 (29) |
| Professor (assistant, associate, full) | 23.5 (47) |
| Other† | 3 (6) |
| Primary affiliation type | |
| Public sector | 68 (130) |
| Private sector | 15.5 (31) |
| Public and private | 15 (30) |
| Other‖ | 1.5 (3) |
| Country of participant | |
| Morocco | 25.5 (51) |
| Turkey | 7 (14) |
| United Kingdom | 5.5 (11) |
| United States of America | 5.5 (11) |
| Bangladesh | 5 (10) |
| Belgium | 5 (10) |
| Kenya | 4.5 (9) |
| Pakistan | 4 (8) |
| Egypt | 4 (8) |
| Ethiopia | 3.5 (7) |
| Kigndom of Saudi Arabia | 2.5 (5) |
| Italy | 2.5 (5) |
| Algeria | 2.5 (5) |
| All other countries₱ | 22.5 (155) |
| Missing data | 0.5 (1) |
| Income group of participants’ country α | |
| Low- and middle-income country | 70.5 (141) |
| High-income country | 29 (58) |
| Missing data | 0.5 (1) |
Abbreviations: MD: medical doctorate, PhD:philosophy doctorate, SD: standard deviation, IQR: interquartile range, MS: master of science, PharmD: Doctorate of pharmacy, MPharm: master of pharmacy. ¥Gynecologic oncology (n=1), pediatric oncology (n=1), digestive oncology (n=1), and one unknown specialty (n=1, the participant indicated physician scientist). ‡PharmD/PhD (n=2), MPhil (n=1). †Research fellow (n=2), PhD candidate (n=1), hospital director (n=1), chief pharmacist (n=1). ‖Academia (n=2), academic private (n=1). ₱details on all countries can be found in Supplement 2 (Table 1). αBased on the World Bank classification (2022 data); available here: https://blogs.worldbank.org/opendata/new-world-bank-country-classifications-income-level-2021-2022. Venezuela, previously classified as a an upper-middle income country, was reclassified as a lower-middle income country (https://publications.iadb.org/en/venezuela-still-upper-middle-income-country-estimating-gni-capita-2015-2021).